Opko Health Inc. (NYSE: OPK) has purchased a 10 percent stake in Oao Pharmsynthez (MICEX: LIFE), a Russian pharmaceutical company.

The deal is part of a $60 million two-stage financing for Oao Pharmsynthez that Opko is contributing to with the Russian Corporation of Nanotechnologies, a state-owned company. The Russian Corporation of Nanotechnologies invested $26.1 million as the first step of the deal. Terms of Opko’s investment weren’t disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.